Addii Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 26-09-2024
- Paid Up Capital ₹ 2.67 Cr
as on 26-09-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.24 Cr
as on 26-09-2024
- Satisfied Charges ₹ 21.30 Cr
as on 26-09-2024
- Revenue 43.21%
(FY 2023)
- Profit 42.01%
(FY 2023)
- Ebitda 26.59%
(FY 2023)
- Net Worth 44.61%
(FY 2023)
- Total Assets 23.62%
(FY 2023)
About Addii Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.67 Cr.
The company currently has active open charges totaling ₹24.24 Cr. The company has closed loans amounting to ₹21.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lalit Dogra and Bijaya Mohanty serve as directors at the Company.
- CIN/LLPIN
U24232CH2011PTC033281
- Company No.
033281
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Addii Biotech Private Limited offer?
Addii Biotech Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Cardiovascular Drugs & Medication, Antidiabetic Medicine, Brain & Nervous System Drugs, Antiepileptic Drugs, Antacid Drugs, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Addii Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Dogra  | Director | 27-Sep-2011 | Current |
| Bijaya Mohanty | Director | 28-May-2018 | Current |
Financial Performance of Addii Biotech.
Addii Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.21% increase. The company also saw a substantial improvement in profitability, with a 42.01% increase in profit. The company's net worth Soared by an impressive increase of 44.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Addii Biotech?
In 2023, Addii Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Jan 2024 | ₹3.50 M | Open |
Sidbi Creation Date: 19 Jul 2023 | ₹2.53 Cr | Open |
Sidbi Creation Date: 05 Jun 2023 | ₹9.85 M | Open |
How Many Employees Work at Addii Biotech?
Addii Biotech has a workforce of 246 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Addii Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Addii Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
